Encompass Health ( (EHC) ) has released its Q4 earnings. Here is a breakdown of the information Encompass Health presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Encompass Health is a leading healthcare provider, known as the largest owner and operator of inpatient rehabilitation hospitals in the United States, focusing on delivering high-quality rehabilitative care.
In its latest earnings report, Encompass Health announced a strong financial performance for the fourth quarter of 2024, with significant revenue growth and improved earnings metrics, setting a positive tone for 2025.
The company reported a 12.7% increase in net operating revenue, totaling $1,405 million, driven by a 7.8% growth in discharges. Adjusted EBITDA also saw a rise of 13.6% to $289.6 million. Notably, the company’s adjusted free cash flow more than doubled to $190.5 million. Earnings per diluted share from continuing operations increased by 25.5% to $1.18, reflecting robust operational efficiency and strategic growth initiatives.
Encompass Health also issued its 2025 guidance, forecasting net operating revenue between $5,800 million to $5,900 million and adjusted EBITDA ranging from $1,160 million to $1,200 million, showcasing its optimistic outlook for continued expansion and market leadership.
Looking ahead, Encompass Health remains confident in its growth strategy and long-term prospects, supported by its commitment to expanding capacity and enhancing patient care, with the management expressing a bullish stance on the future trajectory of the business.
